Treatment Guidelines from The Medical Letter
FROM
ISSUE
73
Drugs for Tobacco Dependence
The full article is available to subscribers Subscriber Login   
Revised 10/6/10: Table 1: Some footnotes were renumbered.

Tobacco dependence is a chronic disease that often requires pharmacological therapy, but counseling improves the effectiveness of any treatment for this indication. The greater the number of office visits and the longer the counseling time, the higher the smoking cessation rates have been.1

FIRST-LINE DRUGS

NICOTINE — All nicotine replacement therapies (NRTs) deliver nicotine, which acts as an agonist at the nicotinic acetylcholine receptor, to the central nervous system (CNS) in a lower dose and at a substantially slower rate than tobacco cigarettes. All of these products roughly double smoking cessation rates.2 Nicotine is subject to first-pass metabolism, limiting the effectiveness of oral pill formulations. Nicotine gum, lozenges and patches are available without a prescription in the US; these products appear to be ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Tobacco Dependence
Article code: 73a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian